Odintsov I, Mattar MS, Lui AJW, Offin M, et al. Novel preclinical patient-derived lung cancer models reveal inhibition of HER3 and MTOR signaling as therapeutic strategies for NRG1 fusion-positive cancers. J Thorac Oncol 2021 Apr 8. pii: S1556-0864(21)02068.
PMID: 33839363